Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 391

    Incentives are given to Farmers for Cultivation of Medicinal Plants: Shri Shripad Naik

    Incentives are given to Farmers for Cultivation of Medicinal Plants: Shri Shripad Naik

    Ruby Khatun Khatun14 Aug 2017 9:49 AM IST
    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through a written reply to a question in Lok Sabha informed that...
    FDA warns of potential contamination in multiple brands of drugs, dietary supplements

    FDA warns of potential contamination in multiple brands of drugs, dietary supplements

    Ruby Khatun Khatun14 Aug 2017 9:30 AM IST
    The U.S. Food and Drug Administration (FDA) is advising consumers and health care professionals not to use any liquid drug or dietary supplement...
    German regulator denies GMP nod to DRLs Bachupally Unit 2

    German regulator denies GMP nod to DRLs Bachupally Unit 2

    Ruby Khatun Khatun13 Aug 2017 10:15 AM IST
    New Delhi: Drug firm Dr Reddy's Laboratories (DRL) said the German regulator has not renewed good manufacturing practice (GMP) compliance certificate...
    53 species of medicinal plants are under threatened categories: AYUSH Minister

    53 species of medicinal plants are under threatened categories: AYUSH Minister

    Ruby Khatun Khatun13 Aug 2017 10:00 AM IST
    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through written reply to a question in Lok Sabha informed that 53...
    Upgrading Food Testing Laboratories: Minister informs Parliament

    Upgrading Food Testing Laboratories: Minister informs Parliament

    Ruby Khatun Khatun13 Aug 2017 9:42 AM IST
    The Minister of State (Health and Family Welfare), Sh Faggan Singh Kulaste through a written reply in the Rajya Sabha informed about the upgradations...
    Cipla hopes to generate sustainable top-line growth in FY18

    Cipla hopes to generate sustainable top-line growth in FY18

    Ruby Khatun Khatun13 Aug 2017 9:20 AM IST
    Mumbai: Cipla on Friday said even as the industry faces several hurdles, the government's new drug policy will boost the pharma sector and the company...
    Mylan cuts forecasts on delays in new drugs, weak prices

    Mylan cuts forecasts on delays in new drugs, weak prices

    Ruby Khatun Khatun13 Aug 2017 9:10 AM IST
    Mylan NV said on Wednesday that delays in launching key new drugs and eroding prices for generics in the United States will hurt its profitability...
    Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US

    Zydus Pharma recalls 3.31 lakh bottles of seizure drug in US

    Ruby Khatun Khatun12 Aug 2017 12:20 PM IST
    New Delhi: Zydus Pharmaceuticals USA Inc is recalling from the US market over 3.31 lakh bottles of Divalproex Sodium delayed release tablets used for...
    Sun Pharma buys stake in US based biopharma company

    Sun Pharma buys stake in US based biopharma company

    Ruby Khatun Khatun12 Aug 2017 9:40 AM IST
    Mumbai: Drug maker, Sun Pharma has acquired 15.9% stake in US-based biopharmaceutical company, Krystal Biotech Inc.One of the wholly-owned...
    Quality standards prescribed in pharmacopoeias mandatory for manufacturing of AYUSH drugs: Shri Shripad Naik

    Quality standards prescribed in pharmacopoeias mandatory for manufacturing of AYUSH drugs: Shri Shripad Naik

    Ruby Khatun Khatun12 Aug 2017 9:40 AM IST
    The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik through a written reply to a question in Lok Sabha informed that the...
    LifeCell Becomes Indias Biggest Cord Blood Stem Cell Registry for Unrelated Use

    LifeCell Becomes Indias Biggest Cord Blood Stem Cell Registry for Unrelated Use

    Ruby Khatun Khatun12 Aug 2017 9:20 AM IST
    Achieves landmark milestone within four months of launch of revolutionary banking modelCHENNAI: In spite of being a highly populated country, India...
    Aster DM Healthcare re-files for  IPO

    Aster DM Healthcare re-files for IPO

    Ruby Khatun Khatun11 Aug 2017 9:36 AM IST
    Mumbai: A draft red herring prospectus (DRHP) has been re-filled by Aster DM Healthcare with a reduced offer size of its initial public offering...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok